✦ LIBER ✦

IL28B in hepatitis C virus infection: translating pharmacogenomics into clinical practice

✍ Scribed by Golo Ahlenstiel; David R. Booth; Jacob George

Book ID: 106180705
Publisher: Springer Japan
Year: 2010
Tongue: English
Weight: 294 KB
Volume: 45
Category: Article
ISSN: 0944-1174
DOI: 10.1007/s00535-010-0287-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Observed and calculated interleukin-28B

Observed and calculated interleukin-28B genotype frequencies in hepatitis C virus infection

✍ Magnus Lindh; Martin Lagging; Gunnar Norkrans; Kristoffer Hellstrand 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 411 KB 👁 2 views

We read with great interest the practice guidelines for the diagnosis and management of autoimmune hepatitis recently issued by the American Association for the Study of Liver Diseases (AASLD). 1 In particular, we appreciate the new definition of biochemical remission, which now requires not only no

Causes of death in hepatitis B and/or C

Causes of death in hepatitis B and/or C virus infected–people—lessons for clinical practice

✍ Frank Tacke; Christian Trautwein 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

Background: Hepatitis B and hepatitis C virus infections are common causes of death related to liver disease. In this large study, we aimed to investigate all cause mortality of the viruses in a community-based setting. Methods: In the study population, 39,109 people had hepatitis B, 75,834 had hepa

Clinical significance of prior hepatitis

Clinical significance of prior hepatitis B virus infection in patients with hepatitis C virus–related hepatocellular carcinoma

✍ Shoji Kubo; Shuhei Nishiguchi; Kazuhiro Hirohashi; Hiromu Tanaka; Tadashi Tsukam 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB 👁 2 views

## BACKGROUND. The effect of prior hepatitis B virus (HBV) infection on the clinicopathologic findings for patients with hepatitis C virus (HCV) RNA and hepatocellular carcinoma (HCC) is still unclear. ## METHODS. Of 59 patients who underwent liver resection for HCV-related HCC (Յ2.0 cm in greate

IL28B genetic variation and treatment re

IL28B genetic variation and treatment response in patients with hepatitis C virus genotype 3 infection

✍ Amir Moghaddam; Espen Melum; Nils Reinton; Helmer Ring-Larsen; Hans Verbaan; Kri 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 325 KB 👁 2 views

Polymorphisms near the IL28B gene, which code for interferon (IFN)-λ3, predict response to pegylated interferon-α (PEG-IFN) and ribavirin treatment in hepatitis C virus (HCV) genotype 1 infected patients. Follow-up studies of the effect of IL28B gene in HCV non-genotype 1 infected patients have almo

Clinical significance of pre-S mutations

Clinical significance of pre-S mutations in patients with genotype C hepatitis B virus infection

✍ M. S. Choi; D. Y. Kim; D. H. Lee; J. H. Lee; K. C. Koh; S. W. Paik; J. C. Rhee; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 608 KB

Potential role for Interleukin-28B genot

Potential role for Interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infection

✍ Jason Grebely; Kathy Petoumenos; Margaret Hellard; Gail V. Matthews; Vijayapraka 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 263 KB 👁 2 views

Polymorphisms in the IL28B (interleukin-28B) gene region are important in predicting outcome following therapy for chronic hepatitis C virus (HCV) infection. We evaluated the role of IL28B in spontaneous and treatment-induced clearance following recent HCV infection. The Australian Trial in Acute He